Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Manuela Matta"'
Autor:
Matteo Bronzini, Alessandro Maglione, Rachele Rosso, Federica Masuzzo, Manuela Matta, Raffaella Meroni, Simona Rolla, Marinella Clerico
Publikováno v:
Nutrients, Vol 16, Iss 6, p 880 (2024)
The Mediterranean Diet (MD) is described in the literature as a beneficial dietary pattern for neurodegenerative diseases such as Multiple Sclerosis (MS). The objective of this study was to evaluate the dietary habits in people with MS (pwMS) and to
Externí odkaz:
https://doaj.org/article/0d96fbccf7c2434c940a2e7d0cd912ee
Autor:
Alessandro Maglione, Rachele Francese, Irene Arduino, Rachele Rosso, Manuela Matta, Simona Rolla, David Lembo, Marinella Clerico
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background and objectivesLong lasting immune response to anti-SARS-CoV-2 vaccination in people with Multiple Sclerosis (pwMS) is still largely unexplored. Our study aimed at evaluating the persistence of the elicited amount of neutralizing antibodies
Externí odkaz:
https://doaj.org/article/4ee016a7513f4ecbb94a2a4be7e157bb
Autor:
Matteo Bronzini, Alessandro Maglione, Rachele Rosso, Manuela Matta, Federica Masuzzo, Simona Rolla, Marinella Clerico
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Multiple sclerosis (MS) is a multifactorial neurological disease characterized by chronic inflammation and immune-driven demyelination of the central nervous system (CNS). The rising number of MS cases in the last decade could be partially attributed
Externí odkaz:
https://doaj.org/article/e00ba7c336144237adeaf2774957e7a9
Autor:
Stefania Federica De Mercanti MD, PhD, Dario Gned MD, Manuela Matta MD, Marco Iudicello MD, Emanuele Franchin MD, Marinella Clerico MD, PhD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Progressive multifocal leukoencephalopathy (PML) is a serious infective disease of the central nervous system that may occur in case of severe immunosuppression or after some treatment for multiple sclerosis (MS) with natalizumab, dimethyl fumarate,
Externí odkaz:
https://doaj.org/article/2ef76c267af84d9da1d347a6aa77fa95
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Multiple sclerosis (MS) commonly causes eye movement abnormalities that may have a significant impact on patients’ disability. Inflammatory demyelinating lesions, especially occurring in the posterior fossa, result in a wide range of disorders, spa
Externí odkaz:
https://doaj.org/article/4b313332cac94d14935dd4f569412bd4
Autor:
Silvia Messina, Claudio Solaro, Isabella Righini, Roberto Bergamaschi, Simona Bonavita, Roberto Bruno Bossio, Vincenzo Brescia Morra, Gianfranco Costantino, Paola Cavalla, Diego Centonze, Giancarlo Comi, Salvatore Cottone, Maura Chiara Danni, Ada Francia, Alberto Gajofatto, Claudio Gasperini, Mauro Zaffaroni, Loredana Petrucci, Elisabetta Signoriello, Giorgia Teresa Maniscalco, Gabriella Spinicci, Manuela Matta, Massimiliano Mirabella, Graziella Pedà, Letizia Castelli, Marco Rovaris, Edoardo Sessa, Daniele Spitaleri, Damiano Paolicelli, Alfredo Granata, Mario Zappia, Francesco Patti, SA.FE. study group
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0180651 (2017)
The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many patients. In Italy, the healthcare payer can be fully reimbursed by the involved pharma company with the cost of treatment for patients
Externí odkaz:
https://doaj.org/article/708f45afdbee4c38ad1ddae8ac4f4507
Autor:
Domenico Ippolito, Giorgia Teresa Maniscalco, Damiano Paolicelli, Daniele Spitaleri, Francesco Patti, Gianfranco Costantino, Margherita Russo, Clara Grazia Chisari, Letizia Castelli, Giovanna Salamone, Roberto Bruno Bossio, Maria Trotta, Claudio Solaro, Eliana Berra, Roberta Lanzillo, Elisabetta Signoriello, Raffaella Cerqua, Isabella Righini, Fabio Buttari, Gabriella Spinicci, Loredana Petrucci, Angelica Guareschi, Manuela Matta, Mario Zappia, Simona Pontecorvo, Maria Donata Benedetti, Paola Cavalla, Assunta Bianco, Claudio Gasperini, Eleonora Tavazzi, Francesco Saccà, Mauro Zaffaroni
Publikováno v:
Neurological Sciences. 41:2905-2913
Introduction: The approval of 9-δ-tetrahydocannabinol (THC)+cannabidiol (CBD) oromucosal spray (Sativex®) in Italy as an add-on medication for the management of moderate to severe spasticity in multiple sclerosis (MS) has provided a new opportunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9f3855c640f0921c03963b4dac58be
https://doi.org/10.1007/s10072-020-04413-6
https://doi.org/10.1007/s10072-020-04413-6
Autor:
Alessandro Maglione, Marta Morra, Raffaella Meroni, Manuela Matta, Marinella Clerico, Simona Rolla
Anti-SARS-CoV2 mRNA vaccines showed a blunted antibody (Ab) response in people with MS (pwMS) on high efficacy therapies, suggesting the need for a booster dose. We evaluated the kinetics of the production of anti-receptor binding domain (RBD) Immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2124f9073a0a829c118d78a46ca1707c
https://hdl.handle.net/2318/1883241
https://hdl.handle.net/2318/1883241
Autor:
Simona Bonavita, Giuseppina Miele, Luigi Lavorgna, Stefania Federica De Mercanti, Marinella Clerico, Manuela Matta, Marco Iudicello, Gianmarco Abbadessa
Background: Friedreich’s ataxia (FRDA) is an untreatable disease that negatively impacts patients’ and caregivers’ quality of life. Objectives: The aims were to improve the quality of the information for FRDA patients and caregivers and suggest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f091958b364b318ff5a33cc2eacebb
http://hdl.handle.net/2318/1844743
http://hdl.handle.net/2318/1844743
Autor:
Dario Gned, Stefania Federica De Mercanti, Manuela Matta, Marinella Clerico, Marco Iudicello, Emanuele Franchin
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Progressive multifocal leukoencephalopathy (PML) is a serious infective disease of the central nervous system that may occur in case of severe immunosuppression or after some treatment for multiple sclerosis (MS) with natalizumab, dimethyl fumarate,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea11b9390bb80355e1db09dd99ca616
https://pubmed.ncbi.nlm.nih.gov/32646245
https://pubmed.ncbi.nlm.nih.gov/32646245